1. Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Cancer Center, Westwood, KS;
2. Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY;
3. Mayo Clinic, Scottsdale, AZ;
4. Division of Hematology, University of Utah School of Medicine and
5. Huntsman Cancer Center, Salt Lake City, UT;
6. Comprehensive Cancer Center, Wake Forest University Medical Center, Wake Forest Health, Winston-Salem, NC;
7. Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD;
8. Division of Hematology and Oncology, Department of Medicine, Richard T. Silver Myeloproliferative Neoplasms Center, Weill Cornell Medical College, New York, NY;
9. Georgetown University Medical Center, Washington, DC;
10. Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA;
11. Department of Hematology, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy;
12. Department of Oncology, University of Milan, Ospedale Papa Giovanni XXIII, Bergamo, Italy;
13. Center for Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero-Universitaria Careggi, and
14. Denothe Excellence Center, University of Florence, Florence, Italy;
15. Department of Oncology, Palo Alto Medical Foundation, Sutter Health, Palo Alto, CA;
16. Division of Hematology and Oncology, University of Illinois, Chicago, IL;
17. Division of Hematology, Duke University School of Medicine, Durham, NC;
18. Department of Oncology, John H. Stroger Jr. Hospital of Cook County, Chicago, IL;
19. Geisinger Medical Center, Danville, PA;
20. Laboratory of Biochemistry, Biotechnology, and Advanced Diagnosis, Center for the Study of Myelofibrosis, Istituto Di Ricovero e Cura a Carattere Scientifico, Foundation Policlinico San Matteo, Pavia, Italy;
21. Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA;
22. Department of Pathology and
23. Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY;
24. Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY;
25. Computational Oncology,
26. Center for Hematological Malignancies, and
27. Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY;
28. Mayo Clinic Laboratories, Rochester, MN;
29. New York Blood Center, New York, NY;
30. Department of Population Health and
31. Department of Environmental Medicine, New York University School of Medicine, New York, NY;
32. Ospedali Riuniti, Bergamo, Italy; and
33. UT Health San Antonio Cancer Center, San Antonio, TX